Use of melatonin to prevent cytotoxic effects of amyloid beta pr

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

548469, A01N 4338

Patent

active

059589647

ABSTRACT:
The present invention is directed to a method of preventing cytotoxic effects of amyloid beta protein on cells. The method comprises exposing the cells to an effective amount of melatonin. The invention further provides a method of treating Alzheimer's disease in a human subject, which comprises administering an amount of melatonin effective to prevent the cytotoxic effects of amyloid beta protein to the human subject.

REFERENCES:
patent: 5449690 (1995-09-01), Lesieur et al.
patent: 5464872 (1995-11-01), Langlois et al.
patent: 5470846 (1995-11-01), Sandyk
patent: 5541228 (1996-07-01), Takaki et al.
patent: 5552418 (1996-09-01), Depreux et al.
patent: 5552428 (1996-09-01), Fraschini et al.
patent: 5554642 (1996-09-01), Langolis et al.
patent: 5580878 (1996-12-01), D'Orlando et al.
patent: 5591775 (1997-01-01), Depreux et al.
patent: 5596019 (1997-01-01), Mattson et al.
patent: 5707652 (1998-01-01), Lewy
Mishima, K. et al., Acta Psychiat Scand 89:1-7 (1994).
Huerto-Delgadillo, L., et al., J Pineal Res 17:55-62 (1994).
Dori, D., et al., Chronobiol 21:121-126 (1994).
Iguchi, H., et al., J Clin Endocrinol Metabol 55:27-29 (1982).
Pappolla, M.A., et al., Mol Chem Neuropathol 28:21-34 (1996).
Pieraoli, W., Aging 3 (2):99-101 (1991).
Pierpaoli, W., et al., Ann NY Acad Sci 621:291-313 (1991).
Reiter, R.J., Exp Gerontol 30:199-212 (1995).
Skene, D.J., et al., Brain Research 528:170-174 (1990).
Souetre, E., et al., Am J Psychiatry 146:1037-1040 (1989).
Mattson, M.P., Ann NY Acad Sci 747:50-76 (1994).
Hensley, K., et al., Proc Natl Acad Sci USA 91(8):3270-3274 (1994).
Pappolla, J. Neurosci. 17, 1683, 1997.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Use of melatonin to prevent cytotoxic effects of amyloid beta pr does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Use of melatonin to prevent cytotoxic effects of amyloid beta pr, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of melatonin to prevent cytotoxic effects of amyloid beta pr will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-703856

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.